CHEMED CORPORATION vs PACS Group, Inc., two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
30.64 sits at the center of this pair: Chemed's return on equity, earned with barely any leverage (0.11 turns), against PACS Group's 23.4% earned with modest gearing in skilled nursing. The multiples nearly touch, 25.3 and 27 times earnings, so the market sees the two as equals despite Chemed's fatter margins, 12.9% against 8.5% operating, and its stranger construction, hospice care and drain cleaning under one roof. PACS answers with cash, a 7.2% free-cash yield against 5.6%, and a similar small dividend. Two high-return care operators priced identically; the reader's choice reduces to which reimbursement stream, hospice or skilled nursing, deserves more trust through the next rate cycle.
Comparison updated 2026-07-10.
| Metric | CHE | PACS |
|---|---|---|
| Price | $462.49 | $41.88 |
| Market cap | $6.3B | $6.8B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Growth |
| Implied growth (priced in) | +4.5% | +7.9% |
| P/E | 25.3 | 27.0 |
| P/B | 7.47 | 6.51 |
| P/S | 2.49 | 1.25 |
| EV/EBITDA | 16.3 | 17.8 |
| Revenue growth | +2.1% | +23.6% |
| Operating margin | 12.9% | 8.4% |
| Net margin | 10.2% | 4.5% |
| Return on equity | 30.6% | 23.4% |
| Return on assets | 16.9% | 4.3% |
| Return on invested capital | 26.1% | 21.0% |
| FCF yield | 5.6% | 7.2% |
| Dividend yield | 0.5% | 0.5% |
| Debt / equity | 0.11 | 0.24 |
| Current ratio | 0.85 | 0.99 |
| Altman Z (solvency) | 10.00 | 2.01 |
| Piotroski F (quality) | 7 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.